Potential of Polyethyleneimine as an Adjuvant To Prepare Long-Term and Potent Antifungal Nanovaccine
BackgroundCandida albicans infections are particularly prevalent in immunocompromised patients. Even with appropriate treatment with current antifungal drugs, the mortality rate of invasive candidiasis remains high. Many positive results have been achieved in the current vaccine development. There a...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.843684/full |
_version_ | 1828796167813595136 |
---|---|
author | Zhao Jin Yi-Ting Dong Shuang Liu Jie Liu Xi-Ran Qiu Yu Zhang Hui Zong Wei-Tong Hou Shi-Yu Guo Yu-Fang Sun Si-Min Chen Hai-Qing Dong Yong-Yong Li Mao-Mao An Hui Shen |
author_facet | Zhao Jin Yi-Ting Dong Shuang Liu Jie Liu Xi-Ran Qiu Yu Zhang Hui Zong Wei-Tong Hou Shi-Yu Guo Yu-Fang Sun Si-Min Chen Hai-Qing Dong Yong-Yong Li Mao-Mao An Hui Shen |
author_sort | Zhao Jin |
collection | DOAJ |
description | BackgroundCandida albicans infections are particularly prevalent in immunocompromised patients. Even with appropriate treatment with current antifungal drugs, the mortality rate of invasive candidiasis remains high. Many positive results have been achieved in the current vaccine development. There are also issues such as the vaccine’s protective effect is not persistent. Considering the functionality and cost of the vaccine, it is important to develop safe and efficient new vaccines with long-term effects. In this paper, an antifungal nanovaccine with Polyethyleneimine (PEI) as adjuvant was constructed, which could elicit more effective and long-term immunity via stimulating B cells to differentiate into long-lived plasma cells.Materials and MethodsHsp90-CTD is an important target for protective antibodies during disseminated candidiasis. Hsp90-CTD was used as the antigen, then introduced SDS to “charge” the protein and added PEI to form the nanovaccine. Dynamic light scattering and transmission electron microscope were conducted to identify the size distribution, zeta potential, and morphology of nanovaccine. The antibody titers in mice immunized with the nanovaccine were measured by ELISA. The activation and maturation of long-lived plasma cells in bone marrow by nanovaccine were also investigated via flow cytometry. Finally, the kidney of mice infected with Candida albicans was stained with H&E and PAS to evaluate the protective effect of antibody in serum produced by immunized mice.ResultsNanoparticles (NP) formed by Hsp90-CTD and PEI are small, uniform, and stable. NP had an average size of 116.2 nm with a PDI of 0.13. After immunizing mice with the nanovaccine, it was found that the nano-group produced antibodies faster and for a longer time. After 12 months of immunization, mice still had high and low levels of antibodies in their bodies. Results showed that the nanovaccine could promote the differentiation of B cells into long-lived plasma cells and maintain the long-term existence of antibodies in vivo. After immunization, the antibodies in mice could protect the mice infected by C. albicans.ConclusionAs an adjuvant, PEI can promote the differentiation of B cells into long-lived plasma cells to maintain long-term antibodies in vivo. This strategy can be adapted for the future design of vaccines. |
first_indexed | 2024-12-12T04:17:51Z |
format | Article |
id | doaj.art-23d975dd68fc465eb022b028a4da268d |
institution | Directory Open Access Journal |
issn | 1664-3224 |
language | English |
last_indexed | 2024-12-12T04:17:51Z |
publishDate | 2022-05-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Immunology |
spelling | doaj.art-23d975dd68fc465eb022b028a4da268d2022-12-22T00:38:24ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-05-011310.3389/fimmu.2022.843684843684Potential of Polyethyleneimine as an Adjuvant To Prepare Long-Term and Potent Antifungal NanovaccineZhao Jin0Yi-Ting Dong1Shuang Liu2Jie Liu3Xi-Ran Qiu4Yu Zhang5Hui Zong6Wei-Tong Hou7Shi-Yu Guo8Yu-Fang Sun9Si-Min Chen10Hai-Qing Dong11Yong-Yong Li12Mao-Mao An13Hui Shen14Department of Pharmacology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Pharmacology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Pharmacology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Pharmacology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Pharmacology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Pharmacology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Pharmacology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Pharmacology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Pharmacology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Pharmacology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Pharmacology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Pharmacology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Pharmacology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Pharmacology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Clinical Laboratory Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, ChinaBackgroundCandida albicans infections are particularly prevalent in immunocompromised patients. Even with appropriate treatment with current antifungal drugs, the mortality rate of invasive candidiasis remains high. Many positive results have been achieved in the current vaccine development. There are also issues such as the vaccine’s protective effect is not persistent. Considering the functionality and cost of the vaccine, it is important to develop safe and efficient new vaccines with long-term effects. In this paper, an antifungal nanovaccine with Polyethyleneimine (PEI) as adjuvant was constructed, which could elicit more effective and long-term immunity via stimulating B cells to differentiate into long-lived plasma cells.Materials and MethodsHsp90-CTD is an important target for protective antibodies during disseminated candidiasis. Hsp90-CTD was used as the antigen, then introduced SDS to “charge” the protein and added PEI to form the nanovaccine. Dynamic light scattering and transmission electron microscope were conducted to identify the size distribution, zeta potential, and morphology of nanovaccine. The antibody titers in mice immunized with the nanovaccine were measured by ELISA. The activation and maturation of long-lived plasma cells in bone marrow by nanovaccine were also investigated via flow cytometry. Finally, the kidney of mice infected with Candida albicans was stained with H&E and PAS to evaluate the protective effect of antibody in serum produced by immunized mice.ResultsNanoparticles (NP) formed by Hsp90-CTD and PEI are small, uniform, and stable. NP had an average size of 116.2 nm with a PDI of 0.13. After immunizing mice with the nanovaccine, it was found that the nano-group produced antibodies faster and for a longer time. After 12 months of immunization, mice still had high and low levels of antibodies in their bodies. Results showed that the nanovaccine could promote the differentiation of B cells into long-lived plasma cells and maintain the long-term existence of antibodies in vivo. After immunization, the antibodies in mice could protect the mice infected by C. albicans.ConclusionAs an adjuvant, PEI can promote the differentiation of B cells into long-lived plasma cells to maintain long-term antibodies in vivo. This strategy can be adapted for the future design of vaccines.https://www.frontiersin.org/articles/10.3389/fimmu.2022.843684/fullpolyethyleniminenanoparticlesfungal infectionslong-lived plasma celllong-term protection |
spellingShingle | Zhao Jin Yi-Ting Dong Shuang Liu Jie Liu Xi-Ran Qiu Yu Zhang Hui Zong Wei-Tong Hou Shi-Yu Guo Yu-Fang Sun Si-Min Chen Hai-Qing Dong Yong-Yong Li Mao-Mao An Hui Shen Potential of Polyethyleneimine as an Adjuvant To Prepare Long-Term and Potent Antifungal Nanovaccine Frontiers in Immunology polyethylenimine nanoparticles fungal infections long-lived plasma cell long-term protection |
title | Potential of Polyethyleneimine as an Adjuvant To Prepare Long-Term and Potent Antifungal Nanovaccine |
title_full | Potential of Polyethyleneimine as an Adjuvant To Prepare Long-Term and Potent Antifungal Nanovaccine |
title_fullStr | Potential of Polyethyleneimine as an Adjuvant To Prepare Long-Term and Potent Antifungal Nanovaccine |
title_full_unstemmed | Potential of Polyethyleneimine as an Adjuvant To Prepare Long-Term and Potent Antifungal Nanovaccine |
title_short | Potential of Polyethyleneimine as an Adjuvant To Prepare Long-Term and Potent Antifungal Nanovaccine |
title_sort | potential of polyethyleneimine as an adjuvant to prepare long term and potent antifungal nanovaccine |
topic | polyethylenimine nanoparticles fungal infections long-lived plasma cell long-term protection |
url | https://www.frontiersin.org/articles/10.3389/fimmu.2022.843684/full |
work_keys_str_mv | AT zhaojin potentialofpolyethyleneimineasanadjuvanttopreparelongtermandpotentantifungalnanovaccine AT yitingdong potentialofpolyethyleneimineasanadjuvanttopreparelongtermandpotentantifungalnanovaccine AT shuangliu potentialofpolyethyleneimineasanadjuvanttopreparelongtermandpotentantifungalnanovaccine AT jieliu potentialofpolyethyleneimineasanadjuvanttopreparelongtermandpotentantifungalnanovaccine AT xiranqiu potentialofpolyethyleneimineasanadjuvanttopreparelongtermandpotentantifungalnanovaccine AT yuzhang potentialofpolyethyleneimineasanadjuvanttopreparelongtermandpotentantifungalnanovaccine AT huizong potentialofpolyethyleneimineasanadjuvanttopreparelongtermandpotentantifungalnanovaccine AT weitonghou potentialofpolyethyleneimineasanadjuvanttopreparelongtermandpotentantifungalnanovaccine AT shiyuguo potentialofpolyethyleneimineasanadjuvanttopreparelongtermandpotentantifungalnanovaccine AT yufangsun potentialofpolyethyleneimineasanadjuvanttopreparelongtermandpotentantifungalnanovaccine AT siminchen potentialofpolyethyleneimineasanadjuvanttopreparelongtermandpotentantifungalnanovaccine AT haiqingdong potentialofpolyethyleneimineasanadjuvanttopreparelongtermandpotentantifungalnanovaccine AT yongyongli potentialofpolyethyleneimineasanadjuvanttopreparelongtermandpotentantifungalnanovaccine AT maomaoan potentialofpolyethyleneimineasanadjuvanttopreparelongtermandpotentantifungalnanovaccine AT huishen potentialofpolyethyleneimineasanadjuvanttopreparelongtermandpotentantifungalnanovaccine |